# Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids

> **NCT01913158** · PHASE2 · COMPLETED · sponsor: **G & W Laboratories Inc.** · enrollment: 150 (actual)

## Conditions studied

- Internal Hemorrhoids

## Interventions

- **DRUG:** Anucort-HC, 25 Mg Rectal Suppository
- **DRUG:** Placebo suppository

## Key facts

- **NCT ID:** NCT01913158
- **Lead sponsor:** G & W Laboratories Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01913158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01913158, "Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01913158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*